Clinical Trial Update: Immunogenicity of a Reduced Primary Schedule for Pneumococcal Conjugate Vaccine in UK Infants [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating immunogenicity of a reduced primary vaccination schedule for a pneumococcal conjugate vaccine in UK infants; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease
• Streptococcus Pneumoniae Infection

Snippet

Sponsor: Public Health England | Conditions: Streptococcus Pneumoniae | Phase 2 | Status: COMPLETED